Kolexia
Le Guen Julien
Médecine interne
Hôpital Européen Georges Pompidou
Paris, France
33 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrillation auriculaire Démence Thromboembolie Sepsie Défaillance cardiaque Vascularite Maladies auto-immunes Hémorragie Fragilité

Industries

Pfizer
3 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Incidence of and risk factors for local complications of peripheral venous catheters in patients older than 70 years: Empirical research quantitative.
Journal of clinical nursing   29 mai 2023
Initiation and development of a percutaneous left atrial appendage closure programme: A French centre's experience and literature review.
Archives of cardiovascular diseases   27 janvier 2023
Assessment of DOACs in GEriatrics (ADAGE) study: Rivaroxaban and apixaban plasma concentrations and thrombin generation profiles in very elderly patients with non valvular atrial fibrillation
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Caring for the patient to the end of life and beyond.
Soins. Gerontologie   03 juin 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Clinical and experimental rheumatology   16 mai 2022
Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction.
ESC heart failure   29 novembre 2021
Glomerular endothelial cell senescence drives age-related kidney disease through PAI-1.
EMBO molecular medicine   02 novembre 2021
ADAGE: Study of Interindividual Variability in the Response to New Oral Direct Anticoagulants (Dabigatran Etexilate, Rivaroxaban or Apixaban) in Patients 80 Years Old and Over, Using a Population Pharmacokinetics Approach.
Essai Clinique (Hôpital Charles-Foix)   26 août 2021
Incidence et facteurs de risque de complication infectieuse liée aux voies veineuses périphériques chez la personne âgée : VVPAGE
22es Journées Nationales d'Infectiologie (Montpellier)   01 août 2021
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Nature   08 juillet 2021